Showing 2,669 results

Filters Content type: News, Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Exposure to HIV through medical procedures

HIV blood disaster: UK families search for the truth

Editor's pick
BBC
10 May 2017
Hepatitis C treatment

BC-developed hepatitis C screening test personalizes treatment for patients

Editor's pick
The Globe and Mail
10 May 2017
New & experimental hepatitis C treatment

Study points to new approach to battling hepatitis C infections

Editor's pick
Eurekalert
8 May 2017
Hepatitis B

Besifovir and tenofovir exalidex look promising as new hepatitis B drugs

News
8 May 2017
Access to healthcare

Louisiana proposes tapping a century-old patent law to cut hepatitis C drug prices

Editor's pick
Washington Post
3 May 2017
Elimination of hepatitis C

New report halves the number of people infected with hepatitis C worldwide

Editor's pick
Science
2 May 2017
New & experimental hepatitis C treatment

China FDA Approves Country’s First All-Oral Regimen for Chronic Hepatitis C, Daklinza® (daclatasvir) in Combination with Sunvepra® (asunaprevir)

Editor's pick
Bristol-Myers Squibb
2 May 2017
Hepatitis C treatment

New website launched to help prevent spread of hepatitis C

Editor's pick
ModernHealthcare.com
28 April 2017
New & experimental hepatitis C treatment

Triple combination cures most hepatitis C patients with prior DAA treatment failure

News
28 April 2017
Hepatitis B

EASL releases updated hepatitis B guidelines at International Liver Congress

News
26 April 2017
Hepatitis B

Switching to TAF for hepatitis B improves kidney function and bone loss

News
26 April 2017
Hepatitis C symptoms & diagnosis

New Canadian guideline: No screening for hepatitis C in adults not at increased risk

Editor's pick
Eurekalert Inf Dis
25 April 2017
Hepatitis C treatment

Generic hepatitis C drugs continue to produce high cure rates

News
24 April 2017
Hepatitis B

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Editor's pick
EASL
24 April 2017
Elimination of hepatitis C

New hepatitis data highlight need for urgent global response

Editor's pick
World Health Organization
21 April 2017
New & experimental hepatitis C treatment

AbbVie combination cures 95% of genotype 3 hepatitis C

News
21 April 2017
Access to healthcare

The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir

Editor's pick
Medicines Patent Pool
21 April 2017
New & experimental hepatitis C treatment

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

News
21 April 2017
Hepatitis C treatment

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

News
21 April 2017
Hepatitis C treatment

European HCV treatment access survey shows big variations in eligibility

News
20 April 2017
Hepatitis C treatment

Curing hepatitis C reduces cardiovascular risk

News
20 April 2017
Hepatitis C symptoms & diagnosis

Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease

Editor's pick
EASL press release
20 April 2017
Hepatitis C treatment

Hepatitis C treatment can be provided successfully at syringe programme sites

News
19 April 2017
Pharmaceutical industry

Top 10 Pharmaceutical Companies 2017

Editor's pick
LinkedIn
18 April 2017